Normal FGF23 Levels in Adult Idiopathic Phosphate Diabetes

作者: M. Laroche , J. F. Boyer , H. Jahafar , J. Allard , I. Tack

DOI: 10.1007/S00223-008-9204-8

关键词: OsteoporosisBone diseaseOsteopeniaPhosphateEndocrinologyParathyroid hormoneInternal medicineMedicineCalciumReabsorptionFibroblast growth factor 23

摘要: Fibroblast growth factor 23 (FGF23), a recently discovered phosphaturic substance playing key role in genetic and oncogenic phosphate diabetes, is involved the physiological regulation of metabolism. Moderate idiopathic diabetes (IPD) leading to male osteoporosis diffuse pain resembling fibromyalgia has been described. The aim our study was define FGF23 mechanism IPD. concerned 29 patients with IPD, mean age 53 ± 11 years, whom 72% were men. Fifteen subjects without bone disease normal serum calcium levels used as controls. Phosphate confirmed by reabsorption level <85% threshold (TmPO4/GFR) <0.83. Known causes excluded. Fasting FGF23, phosphate, 1-25(OH)2D3, parathyroid hormone measured compared healthy Spinal hip mineral density (BMD) osteodensitometry. Sixteen had pain, 10 according World Health Organization criteria, 11 osteopenia. Serum significantly lower than controls, but did not differ. Compared status, osteopenia decreased levels, whereas identical two groups. In all patients, positively correlated 1-25(OH)2D3 negatively correlated. seems be cause FGF23/phosphate/1-25(OH)2D3 axis appeared functional.

参考文章(36)
Poiraudeau S, Amor B, Friedlander G, Clemente-Coelho Pj, Rajzbaum G, Adult-onset idiopathic phosphate diabetes. I. Chronic pseudoinflammatory back pain and osteopenia. Revue du rhumatisme (English ed.). ,vol. 62, pp. 175- ,(1995)
Kenneth E. White, Wayne E. Evans, Jeffery L.H. O'Riordan, Marcy C. Speer, Michael J. Econs, Bettina Lorenz-Depiereux, Monika Grabowski, Thomas Meitinger, Tim M. Strom, Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nature Genetics. ,vol. 26, pp. 345- 348 ,(2000) , 10.1038/81664
Makoto Kakitani, Toshiro Fujita, Seiji Fukumoto, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa, Yuji Yamazaki, Kazuma Tomizuka, Yasuhiro Takeuchi, Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism Journal of Clinical Investigation. ,vol. 113, pp. 561- 568 ,(2004) , 10.1172/JCI19081
S.C. Schiavi, Fibroblast growth factor 23: the making of a hormone. Kidney International. ,vol. 69, pp. 425- 427 ,(2006) , 10.1038/SJ.KI.5000168
Dominique Prié, Virginie Huart, Naziha Bakouh, Gabrielle Planelles, Olivier Dellis, Bénédicte Gérard, Philippe Hulin, François Benqué-Blanchet, Caroline Silve, Bernard Grandchamp, Gérard Friedlander, Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter The New England Journal of Medicine. ,vol. 347, pp. 983- 991 ,(2002) , 10.1056/NEJMOA020028
Marc K. Drezner, PHEX gene and hypophosphatemia Kidney International. ,vol. 57, pp. 9- 18 ,(2000) , 10.1046/J.1523-1755.2000.00807.X
John M. Land, Graham J. Kemp, Doris J. Taylor, Susan J. Standing, George K. Radda, B. Rajagopalan, Oral phosphate supplements reverse skeletal muscle abnormalities in a case of chronic fatigue with idiopathic renal hypophosphatemia Neuromuscular Disorders. ,vol. 3, pp. 223- 225 ,(1993) , 10.1016/0960-8966(93)90063-P
M. C. de Vernejoul, P. Marie, D. Kuntz, J. Gueris, L. Miravet, A. Ryckewaert, Nonosteomalacic osteopathy associated with chronic hypophosphatemia. Calcified Tissue International. ,vol. 34, pp. 219- 223 ,(1982) , 10.1007/BF02411240
Suzanne M. Jan de Beur, Tumor-Induced Osteomalacia JAMA. ,vol. 294, pp. 1260- 1267 ,(2005) , 10.1001/JAMA.294.10.1260
Theresa J. Berndt, Theodore A. Craig, Daniel J. McCormick, Beate Lanske, Despina Sitara, Mohammed S. Razzaque, Marlon Pragnell, Ann E. Bowe, Stephen P. O’Brien, Susan C. Schiavi, Rajiv Kumar, Biological activity of FGF-23 fragments. Pflügers Archiv: European Journal of Physiology. ,vol. 454, pp. 615- 623 ,(2007) , 10.1007/S00424-007-0231-5